Cargando…
P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428703/ http://dx.doi.org/10.1097/01.HS9.0000968852.56785.3a |
| _version_ | 1785090532540678144 |
|---|---|
| author | Mehta, Priyanka Campbell, Victoria Maddox, Jamie Floisand, Yngvar O’nions, Jenny Cross, Joe Coats, Thomas Lynam, Mark Roset, Montse Medalla, Greg Park, Saemi Kuter, Hayley Legg, Alex Khan, Anjum |
| author_facet | Mehta, Priyanka Campbell, Victoria Maddox, Jamie Floisand, Yngvar O’nions, Jenny Cross, Joe Coats, Thomas Lynam, Mark Roset, Montse Medalla, Greg Park, Saemi Kuter, Hayley Legg, Alex Khan, Anjum |
| author_sort | Mehta, Priyanka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428703 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287032023-08-17 P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS Mehta, Priyanka Campbell, Victoria Maddox, Jamie Floisand, Yngvar O’nions, Jenny Cross, Joe Coats, Thomas Lynam, Mark Roset, Montse Medalla, Greg Park, Saemi Kuter, Hayley Legg, Alex Khan, Anjum Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428703/ http://dx.doi.org/10.1097/01.HS9.0000968852.56785.3a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mehta, Priyanka Campbell, Victoria Maddox, Jamie Floisand, Yngvar O’nions, Jenny Cross, Joe Coats, Thomas Lynam, Mark Roset, Montse Medalla, Greg Park, Saemi Kuter, Hayley Legg, Alex Khan, Anjum P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS |
| title | P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS |
| title_full | P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS |
| title_fullStr | P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS |
| title_full_unstemmed | P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS |
| title_short | P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS |
| title_sort | p486: real-world effectiveness and safety of cpx-351 in patients aged <60 and ≥60 years with newly diagnosed acute myeloid leukemia: crest-uk post-hoc analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428703/ http://dx.doi.org/10.1097/01.HS9.0000968852.56785.3a |
| work_keys_str_mv | AT mehtapriyanka p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT campbellvictoria p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT maddoxjamie p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT floisandyngvar p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT onionsjenny p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT crossjoe p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT coatsthomas p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT lynammark p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT rosetmontse p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT medallagreg p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT parksaemi p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT kuterhayley p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT leggalex p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis AT khananjum p486realworldeffectivenessandsafetyofcpx351inpatientsaged60and60yearswithnewlydiagnosedacutemyeloidleukemiacrestukposthocanalysis |